Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial

Toni-Karri Pakarinen; Heikki-Jussi Laine; Heikki Mäenpää; Mika Kähönen; Pentti Mattila; Jorma Lahtela

doi:10.1016/j.fas.2012.12.007

Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial

Foot and Ankle Surgery ◽

10.1016/j.fas.2012.12.007 ◽

2013 ◽

Vol 19 (2) ◽

pp. 121-124 ◽

Cited By ~ 13

Author(s):

Toni-Karri Pakarinen ◽

Heikki-Jussi Laine ◽

Heikki Mäenpää ◽

Mika Kähönen ◽

Pentti Mattila ◽

...

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Randomized Trial ◽

Bone Mineral ◽

Prospective Randomized Trial ◽

Mineral Density ◽

Charcot Neuroarthropathy

Download Full-text

MP-08.12: One single dose of zoledronic acid (Zometa) annually can prevent bone mineral density (BMD) in patients with prostate cancer treated with LHRH: early results of a randomized trial

Urology ◽

10.1016/j.urology.2007.06.316 ◽

2007 ◽

Vol 70 (3) ◽

pp. 80-81

Author(s):

A. Lekas ◽

M. Chrisofos ◽

I. Fokitis ◽

A. Balangas ◽

A. Kollias ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Mineral Density ◽

Single Dose ◽

Zoledronic Acid ◽

Randomized Trial ◽

Bone Mineral ◽

Mineral Density ◽

Early Results

Download Full-text

Review for "Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial"

10.1002/jbmr.4106/v2/review2 ◽

2020 ◽

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Randomised Controlled Trial ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Bone Microarchitecture ◽

Controlled Trial ◽

Androgen Deprivation ◽

Mineral Density ◽

Randomised Controlled

Download Full-text

Review for "Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial"

10.1002/jbmr.4106/v1/review1 ◽

2020 ◽

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Randomised Controlled Trial ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Bone Microarchitecture ◽

Controlled Trial ◽

Androgen Deprivation ◽

Mineral Density ◽

Randomised Controlled

Download Full-text

Fracture and bone mineral density outcomes after bisphosphonate discontinuation in children with osteogenesis imperfecta treated with zoledronic acid compared to pamidronate

Bone Abstracts ◽

10.1530/boneabs.4.p39 ◽

2015 ◽

Author(s):

Ryan Heksch ◽

Sasigarn Bowden ◽

Scott Hickey ◽

John Mahan

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Osteogenesis Imperfecta ◽

Bone Mineral ◽

Mineral Density

Download Full-text

Faculty Opinions recommendation of Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1116508.572539 ◽

2008 ◽

Author(s):

Girish Putcha

Keyword(s):

Bone Mineral Density ◽

Parathyroid Hormone ◽

Randomized Trial ◽

Bone Mineral ◽

Mineral Density

Download Full-text

Faculty Opinions recommendation of Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13377017.14747132 ◽

2011 ◽

Author(s):

James Triffitt ◽

Xuchen Duan

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Turnover ◽

Bone Mineral ◽

Secondary Osteoporosis ◽

Mineral Density

Download Full-text

14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70046-x ◽

2010 ◽

Vol 8 (3) ◽

pp. 62

Author(s):

P. Hadji ◽

A. Kauka ◽

M. Kalder ◽

T. Bauer ◽

U. Albert ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Adjuvant Chemotherapy ◽

Bone Mineral ◽

Hormone Receptor ◽

Premenopausal Women ◽

Endocrine Treatment ◽

Mineral Density ◽

Hormone Receptor Positive

Download Full-text

SAT0361 Comparison of the efficacy of annual zoledronic acid or weekly alendronate. A 3-yr analysis of postmenopausal women with low bone mineral density

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.3307 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 594.1-594

Author(s):

L.P. Robles-Carranza ◽

V. Chavez-Valencia ◽

C.A. Arce-Salinas

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Postmenopausal Women ◽

Bone Mineral ◽

Mineral Density ◽

Low Bone Mineral Density

Download Full-text

Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study

Orthopaedic Surgery ◽

10.1111/os.12307 ◽

2017 ◽

Vol 9 (1) ◽

pp. 103-109 ◽

Cited By ~ 4

Author(s):

Bo-cheng Liang ◽

Zhen-yu Shi ◽

Bo Wang ◽

Peng Wu ◽

Ling-cheng Kong ◽

...

Keyword(s):

Bone Mineral Density ◽

Clinical Study ◽

Zoledronic Acid ◽

Bone Turnover ◽

Bone Mineral ◽

Bone Turnover Markers ◽

East China ◽

Newly Diagnosed ◽

Mineral Density ◽

Turnover Markers

Download Full-text

Prevention of Bone Mineral Loss by Zoledronic Acid in Men with Prostate Carcinoma Receiving Androgen Deprivation Therapy: A Prospective Randomized Trial in an Indian Population

Current Urology ◽

10.1159/000115412 ◽

2008 ◽

Vol 2 (2) ◽

pp. 79-86 ◽

Cited By ~ 1

Author(s):

M.P. Rao ◽

Abhay Kumar ◽

Neeraj K. Goyal ◽

Sameer Trivedi ◽

Udai S. Dwivedi ◽

...

Keyword(s):

Zoledronic Acid ◽

Randomized Trial ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Prostate Carcinoma ◽

Indian Population ◽

Androgen Deprivation ◽

Prospective Randomized Trial ◽

Bone Mineral Loss ◽

Mineral Loss

Download Full-text